Literature DB >> 10940383

A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.

J Akai1, N Makita, H Sakurada, N Shirai, K Ueda, A Kitabatake, K Nakazawa, A Kimura, M Hiraoka.   

Abstract

Mutations in the human cardiac Na+ channel alpha subunit gene (SCN5A) are responsible for Brugada syndrome, an idiopathic ventricular fibrillation (IVF) subgroup characterized by right bundle branch block and ST elevation on an electrocardiogram (ECG). However, the molecular basis of IVF in subgroups lacking these ECG findings has not been elucidated. We performed genetic screenings of Japanese IVF patients and found a novel SCN5A missense mutation (S1710L) in one symptomatic IVF patient that did not exhibit the typical Brugada ECG. Heterologously expressed S1710L channels showed marked acceleration in the current decay together with a large hyperpolarizing shift of steady-state inactivation and depolarizing shift of activation. These findings suggest that SCN5A is one of the responsible genes for IVF patients who do not show typical ECG manifestations of the Brugada syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940383     DOI: 10.1016/s0014-5793(00)01875-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

Review 1.  Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Authors:  Mackenzi Mbai; Sridharan Rajamani; Brian P Delisle; Blake D Anson; Corey Anderson; Jonathan C Makielski; Craig T January
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

2.  Structural effects of an LQT-3 mutation on heart Na+ channel gating.

Authors:  M Tateyama; H Liu; A-S Yang; J W Cormier; R S Kass
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 3.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  FGF13 modulates the gating properties of the cardiac sodium channel Nav1.5 in an isoform-specific manner.

Authors:  Jing Yang; Zhihua Wang; Daniel S Sinden; Xiangchong Wang; Bin Shan; Xiao Yu; Hailin Zhang; Geoffrey S Pitt; Chuan Wang
Journal:  Channels (Austin)       Date:  2016-05-31       Impact factor: 2.581

Review 5.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

Review 6.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

7.  Genetic analysis of the cardiac sodium channel gene SCN5A in Koreans with Brugada syndrome.

Authors:  Dong-Jik Shin; Yangsoo Jang; Hyun-Young Park; Jong Eun Lee; Keumjin Yang; Eunmin Kim; Yoonjung Bae; Jongmin Kim; Jeongki Kim; Sung Soon Kim; Moon Hyoung Lee; Mohamed Chahine; Sungjoo Kim Yoon
Journal:  J Hum Genet       Date:  2004-08-26       Impact factor: 3.172

Review 8.  The outer vestibule of the Na+ channel-toxin receptor and modulator of permeation as well as gating.

Authors:  René Cervenka; Touran Zarrabi; Peter Lukacs; Hannes Todt
Journal:  Mar Drugs       Date:  2010-04-21       Impact factor: 5.118

9.  The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.

Authors:  Yanmin Zhang; Juanli Wang; Suer Chang; Nan Zhou; Haijian Xing; Lei Wang; Chen Huang; Aiqun Ma; Christopher L-H Huang; Ming Lei; James A Fraser
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

10.  Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel.

Authors:  Y Zhang; T Wang; A Ma; X Zhou; J Gui; H Wan; R Shi; C Huang; A A Grace; C L-H Huang; D Trump; H Zhang; T Zimmer; M Lei
Journal:  Acta Physiol (Oxf)       Date:  2008-07-24       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.